Denosumab Therapy Beyond 10 Years: Subsequent Treatment and Densitometric Outcomes

Key Points

• Densitometric outcomes show significant changes after 10 years of denosumab therapy, indicating potential long-term effects on bone health.
• Patients receiving denosumab therapy demonstrated a considerable change in bone mineral density over the treatment duration.
• Observational analysis assessed outcomes in patients continuing denosumab therapy, emphasizing the importance of sustained treatment.
• Long-term denosumab therapy may necessitate subsequent treatment strategies to manage osteoporosis effectively.